GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » ROCE %

SynBiotic SE (XTER:SBX) ROCE % : -110.88% (As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SynBiotic SE's annualized ROCE % for the quarter that ended in Dec. 2022 was -110.88%.


SynBiotic SE ROCE % Historical Data

The historical data trend for SynBiotic SE's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE ROCE % Chart

SynBiotic SE Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial -5.37 -6.42 -32.67 -57.42 -37.80

SynBiotic SE Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only -2.45 -51.61 -4.68 -110.88 -

SynBiotic SE ROCE % Calculation

SynBiotic SE's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-11.676/( ( (40.624 - 5.74) + (34.918 - 8.018) )/ 2 )
=-11.676/( (34.884+26.9)/ 2 )
=-11.676/30.892
=-37.80 %

SynBiotic SE's ROCE % of for the quarter that ended in Dec. 2022 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2022 )  (Q: Jun. 2022 )(Q: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2022 )  (Q: Jun. 2022 )(Q: Dec. 2022 )
=-49.422/( ( (55.225 - 0.962) + (40.624 - 5.74) )/ 2 )
=-49.422/( ( 54.263 + 34.884 )/ 2 )
=-49.422/44.5735
=-110.88 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2022) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SynBiotic SE  (XTER:SBX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


SynBiotic SE ROCE % Related Terms

Thank you for viewing the detailed overview of SynBiotic SE's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


SynBiotic SE Business Description

Traded in Other Exchanges
N/A
Address
Barer Strasse 7, Munich, BY, DEU, 80333
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Executives
Daniel Kruse Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines